As private funding of biomedical research soars, new risks arise

(Mary Ann Liebert, Inc./Genetic Engineering News) Academic medical centers (AMCs) in the US are navigating an increasing shift in research funding from historic public funding (e.g., NIH) to private sources such as pharma and biotech companies, foundations, and charities, raising a host of new issues related to collaborative research models, intellectual property rights, and scientific and ethical oversight.

from EurekAlert! - Social and Behavioral Science http://ift.tt/2jrci45